The BIA focuses on young scientists and acts as a think tank for strategic personnel development in biomedicine and for new models of academic innovation. In addition, the BIA develops incentive measures for successful translational careers.
Prof. Dr. med. Nathanael Raschzok, Fellow of the BIH Charité Advanced Clinician Scientist Pilot Program, and his research group at the Department of Surgery have received funding from German Cancer Aid (Deutsche Krebshilfe) for the multicenter GTO-001 trial. It aims to give patients with…
Knee osteoarthritis is one of the most common causes of chronic pain and disability worldwide. For many patients, conservative measures do not provide sufficient relief, while joint replacement is either not yet an option or not desired. For this large patient group, very few established treatment…
To ensure that people are not only treated when they are ill, but that diseases do not develop in the first place, medicine must systematically incorporate preventive measures. The BIH Biomedical Innovation Academy (BIA) and Charité – Universitätsmedizin Berlin are launching their Advanced Clinician…
Since the last certificate award ceremony at the International Clinician Scientist Symposium (June 2024), more than 60 program participants have completed their BIH Charité (Junior) (Digital) (Advanced) Clinician Scientist training. This means that the alumni community continues to grow – we are…
This year, the retreat took us and around 150 participants to the “Villa Elisabeth” in Berlin Mitte for an inspiring day. The aim of the one-day CSP retreat was to strengthen the interdisciplinary networking of the fellows. The (Junior) (Digital) Clinician Scientists helped design the program from…
In a study published at the end of August in the journal Molecular Therapy, Michael Kaminski, Verena Klämbt, and Matteus Krappitz – all participants of the BIH Charité Clinician Scientist Program – report an advancement in the fight against autosomal dominant polycystic kidney disease (ADPKD). The…
In a study recently published in JACC: Cardiovascular Imaging, PD Dr. Simon Hellwig, Fellow of the BIH Charité Clinician Scientist Program, and Prof. Dr. Jan F. Scheitz, Fellow of the BIH Charité Advanced Clinician Scientist Pilotprogram, report novel insights into the prognostic relevance of…
Myasthenia gravis is a rare neurological autoimmune disease characterized by fluctuating muscle weakness that worsens with activity. About 17,000 people in Germany suffer from the disease. Many struggle to access appropriate care, especially if they need complex immunotherapies. The start-up…
Dr. med. Livius Penter, internist, and Dr. med. Jana Ihlow, pathologist, are fellows in the Clinician Scientist Program researching how allogeneic stem cell transplants and immunotherapeutic strategies can be used to treat acute myeloid leukaemia (AML). The Brigitte and Dr. Konstanze Wegener…
On April 8, 2025, the kick-off meeting of the first fellows of the nTTP-GCT program took place in Berlin. In an informal atmosphere, the fellows exchanged ideas and were informed about the program components and aims of the National Strategy for GCT. A successful start for the GCT funding of…
Together with the Biomedical Innovation Academy of the Berlin Institute of Health at Charité (BIH), Stiftung Charité 2024 has developed two new funding programs. The first fellows have now been selected.
The BIH Charité (J)CSP is a modern career path in university medicine to provide physicians with a structured residency training with "protected time" for research.
This course was designed with the aim of implementing a modular course for doctoral students focused on Responsible Research that addresses usually underrepresented research topics.
